Dr. Vellanki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Ave
Rm 2181
Silver Spring, MD 20993Phone+1 301-796-9366
Summary
- I am a board certified oncologist and I work at the FDA reviewing clinical trials for thoracic and head and neck cancers. I also care for patients with head and neck cancer in clinic at the University of Maryland, School of Medicine. My interests include cancer genetics, precision medicine, and drug development.
Education & Training
- Johns Hopkins UniversityFellowship, Medical Oncology, 2017 - 2019
- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2013 - 2016
- University of Maryland School of MedicineClass of 2013
Certifications & Licensure
- MD State Medical License 2016 - 2026
- NC State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 28 citationsImmune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and OutcomesAanika Balaji, Jiajia Zhang, Beatriz Wills, Kristen A. Marrone, Hany Elmariah
Journal of Oncology Practice. 2019-08-06 - 30 citationsFDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma.Erica C Nakajima, Paz J. Vellanki, Erin Larkins, Somak Chatterjee, Pallavi S. Mishra-Kalyani
Clinical Cancer Research. 2021-08-30 - 83 citationsLong telomeres and cancer risk: the price of cellular immortality.Emily McNally, Paz J. Luncsford, Mary Armanios
The Journal of Clinical Investigation. 2019-09-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: